Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism VSIG4 modulators(V-set and immunoglobulin domain-containing protein 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | FR | - | |
Solid tumor | Preclinical | KR | - | |
Solid tumor | Preclinical | FR | - |